Understand the source comparison
Best BAC Water for Sterile Dilution: Formulation Comparison
Before selecting your bacteriostatic water source, compare these critical specifications across the most common formulation types available to research labs. USP Pharmaceutical BAC Water 0.9% (9mg/mL) Sterile Water for Injection (USP) 5.0–7.0 buffered 0.22-mic
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Before selecting your bacteriostatic water source, compare these critical specifications across the most common formulation types available to research labs.
- USP Pharmaceutical BAC Water
- 0.9% (9mg/mL)
- Sterile Water for Injection (USP)
- 5.0–7.0 buffered
- 0.22-micron filtration + autoclave
- 28 days refrigerated
- Gold standard for research peptides. Meets all FDA compounding pharmacy requirements and maintains preservative efficacy through full use period
- Budget BAC Water
- 0.5–0.7%
- Sterile water (non-USP)
- 4.5–8.0 unbuffered
- Autoclave only
- 14–21 days claimed
- Insufficient preservative concentration for 28-day safety margin; pH drift risk; acceptable only for single-use immediate reconstitution
- Preservative-Free Sterile Water
- 0% (none)
- Sterile Water for Injection
- 5.0–7.0
- 0.22-micron filtration
- Single-use only
- Required for neonatal applications; no multi-dose protection; must discard remaining solution after each access
- Normal Saline 0.9% NaCl
- Sterile Water for Injection + sodium chloride
- 4.5–7.0
- Autoclave
- Isotonic but lacks preservative; some peptides aggregate in ionic solutions; verify compatibility before use
- 'Research Grade' BAC Water
- 0.8–1.0% (unspecified)
- De-ionized water (laboratory grade)
- Unspecified
- Filtration
- Not validated
- Common in grey-market suppliers; lacks USP traceability; benzyl alcohol purity unverified; pyrogen content unknown
- The comparison reveals why Bacteriostatic Water formulated to USP pharmaceutical standards remains the only defensible choice for multi-dose research peptide reconstitution. The 0.9% benzyl alcohol specification isn't a starting point for negotiation. It's the minimum effective concentration validated across decades of clinical use in multi-dose injectable formulations including insulin, heparin, and corticosteroids.